能倍乐适用于什么病症?
COPD (chronic obstructive pulmonary disease) is a common respiratory disease with high morbidity and mortality rates and is highly harmful. Everyone needs early treatment to prevent complications. In daily life, you should quit smoking, prevent colds and engage in regular physical exercise. The diet should be light, eat more fruits and vegetables, and eat small meals frequently. The main ingredient is tiotropium bromide, which is a bronchodilator. What diseases is Respimat suitable for?
Indications of Respimat: It is suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the maintenance treatment of accompanying dyspnea and the prevention of acute exacerbations. It can improve the quality of life of COPD patients and reduce acute exacerbations of COPD.
The TOviTO Phase III clinical research project fully confirmed the effectiveness and safety of Respimat in the treatment of COPD.
The TOviTO project includes 8 series of clinical studies, enrolling more than 15,000 COPD patients worldwide. The results show that Respimat can further improve the main clinical indicators of COPD (including lung function, dyspnea, acute exacerbation and quality of life) compared with tiotropium spray. Multiple studies have unanimously proven that the efficacy is completely superior to tiotropium bromide as a dual bronchodilator, and the safety is equivalent to single drug treatment.
Subgroup analysis of the TONADO study (including 549 Chinese patients) and the recently published VESUTO study further confirmed that the efficacy of Respimat in treating East Asian patients with COPD is consistent with global data. In addition, a number of authoritative studies have shown that dual bronchodilators, represented by ICS, are better than glucocorticoids/long-acting β2-receptor agonists (ICS/LABA) in improving lung function, relieving dyspnea, and preventing acute exacerbations.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)